Variations in free radical scavenging capacity and antiproliferative activity among different genotypes of autumn olive (Elaeagnus umbellata)

Planta Medica

Volumn 73, Issue 5, 2007, Pages 468-477

  Wang, Shiow Y ^a   Bowman, Linda ^b   Ding, Min ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Antioxidant capacity; Antiproliferation; Apoptotic cancer cells; Autumn olive; Elaeagnus umbellata thunb; Oleaster (Elaeagnaceae)

Indexed keywords

ELAEAGNUS UMBRELLATA EXTRACT; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; ELAEAGNACEAE; ELAEAGNUS UMBELLATA; ELECTRON SPIN RESONANCE; EPIDERMIS CELL; GENOTYPE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ULTRAVIOLET B RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAROTENOIDS; CELL LINE; CELL PROLIFERATION; ELAEAGNACEAE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FRUIT; GENOTYPE; HL-60 CELLS; HUMANS; MICE; PLANT EXTRACTS;

ELAEAGNACEAE; ELAEAGNUS ANGUSTIFOLIA; ELAEAGNUS UMBELLATA;

EID: 34250349624     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967175     Document Type: Article

References (40)

1. Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem 1998; 46: 4113-7.
2. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research; 1997.
3. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: A review. Int J Epidemiol 1977; 26: 1-13.
4. Dirr MA. Manual of woody landscape plants. Champaign: Stipes Publ. Co; 1983.
5. Fordham IM, Clevidence BA, Wiley ER, Zimmerman RH. Fruit of autumn olive: A rich source of lycopene. HortScience 2001; 36: 1136-7.
6. Foote CS, Denny RW. Chemistry of singlet oxygen. VII. Quenching by β-carotene. J Am Chem Soc 1968; 90: 6233-5.
7. Burton GW, Ingold KU. β-Carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569-73.
8. Larson RA. The antioxidants of higher plants. Phytochemistry 1988; 27: 969-78.
9. Pallett KE, Young AJ. Carotenoids. In: Alscher RG, Hess JL, editors. Anti-oxidants in higher plants Boca Raton: CRC; 1993: 71-4.
10. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr 1993; 13: 561-73.
11. Palozza P, Krinsky NI. Antioxidant effects of carotenoids in vitro and vivo: An overview. Methods Enzymol 1992; 213: 403-20.
12. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Flavonoid intake and lung cancer risk. J Natl Cancer Inst 2000; 92: 154-60.
13. Nishino H. Cancer prevention by natural carotenoids. In: Packer L, Hiramatsu M, Yoshikawa T, editors. Antioxidants food supplements in human health New York: Academic Press; 1999.
14. Mathews-Roth MM. Antitumor activity of beta-carotene, canthaxanthin and phytoene. Oncology 1982; 39: 33-7.
15. Ukai N, Lu Y, Etoh H, Yagi A, Ina K, Oshima S et al. Photosensitized oxygenation of lycopene. Biosci Biotechnol Biochem 1994; 58: 1718-9.
16. Giovannucci E. Tomatoes, tomato-based products, lycopene and cancer: review of the epidemiological literature. J Natl Cancer Inst 1999; 91: 317-31.
17. Olson JA. Carotenoids. In: Shils ME, Olson JA, Shik M, Ross AC, editors. Modern nutrition in health and disease. 9th edition. Baltimore: Williams & Wilkins; 1999: 525-41.
18. Weisburger JH. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants and carotenoids. Am J Clin Nutr 1991; 53: 226S-37S.
19. Bode AM, Dong Z. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 2000; 1: 181-8.
20. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-83.
21. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997; 57: 414-9.
22. Hou DX, Kai K, Li JJ, Lin S, Terahara N, Wakamatsu M et al. Anthocyanidins inhibit activator protein 1 activity and cell transforation: structure-activity relationship and molecular mechanisms. Carcinogenesis 2004; 25: 29-36.
23. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997; 198: 35-49.
24. Li JJ, Westergaard C, Ghosh P, Colburn NH. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 1997; 57: 3569-6.
25. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 2003; 309: 1017-26.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival-application to proliferation and cyto-toxicity assays. J. Immunol Methods 1983; 65: 55-63.
27. NCS S. Statistical analysis and graphics. Statistical software. Kaysville, Utah: 2007.
28. Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11: 301-13.
29. Huang CS, Ma WY, Dawson MI, Rincon M, Flavell RA, Dong ZG. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 1997; 94: 5826-30.
30. Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene 1998; 16: 3057-68.
31. Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA, Cross-Doersen DE. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ 1996; 7: 351-9.
32. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH et al. c-Fos is required for malignant progression of skin tumors. Cell 1995; 82: 721-32.
33. Dong Z, Huang C, Brown RE, Ma W-Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 1997; 272: 9962-70.
34. Hsu T, Young MR, Cmarik J, Colburn NH. Activator protein 1 (AP-1)-and nuclear factor κB (NF-κB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000; 28: 1338-48.
35. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342-8.
36. Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 1999; 38: 133-42.
37. Olsson ME, Gustavsson K, Andersson S, Nilsson Å, Duan R. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem 2004; 52: 7264-71.
38. Prakash P, Russel RM, Krinsky NI. In vitro inhibition of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J Nutr 2001; 131: 1574-80.
39. Wang SY, Feng R, Bowman L, Penhallegon R, Ding M, Lu Y. Antioxidant activity in lingonberries (Vaccinium vitis-idaea L) and its inhibory effect on activator protein 1, nuclear factor-κB, and MAPK-activated protein kinases activation. J Agric Food Chem 2005; 53: 3156-66.
40. Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, Xu Y et al. Inhibition of cellular transformation by berry extracts. Carcinogenesis (Lond.) 2001; 22: 351-6.